120 related articles for article (PubMed ID: 7562045)
21. Early dynamic bone-imaging as an indicator of osseous blood flow and factors affecting the uptake of 99mTc hydroxymethylene diphosphonate in healing bone.
Nutton RW; Fitzgerald RH; Kelly PJ
J Bone Joint Surg Am; 1985 Jun; 67(5):763-70. PubMed ID: 3997929
[TBL] [Abstract][Full Text] [Related]
22. [Radioisotopic study of bone growth and maturation. 160 cases].
Guillet J; Guillet C; Blanquet P
Sem Hop; 1982 Oct; 58(38):2199-202. PubMed ID: 6294861
[TBL] [Abstract][Full Text] [Related]
23. The visualization of femoral vessels in delayed bone scans--a sign of arteriosclerosis? A comparison of 99mTc-MDP and 99mTc-DPD.
Lantto T; Järvi K; Toivio I; Vähätalo S; Vorne M
Eur J Nucl Med; 1989; 15(5):265-8. PubMed ID: 2759127
[TBL] [Abstract][Full Text] [Related]
24. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
Kumar V; Kumar D; Howman-Giles RB; Little DG
Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
[TBL] [Abstract][Full Text] [Related]
25. Tc-99m hydroxymethylene diphosphonate and Tc-99m methylene diphosphonate: biological and clinical comparison: concise communication.
Littlefield JL; Rudd TG
J Nucl Med; 1983 Jun; 24(6):463-6. PubMed ID: 6222166
[TBL] [Abstract][Full Text] [Related]
26. The effect of methylene diphosphonate on the tissue distribution of gallium-67.
Downing D; Aburano T; Bushberg J; Hoffer PB
J Nucl Med; 1985 Oct; 26(10):1202-5. PubMed ID: 3862767
[TBL] [Abstract][Full Text] [Related]
27. Soft-tissue uptake of technetium-99m-MDP after prostate cryoablation.
Zucker I; Charkes ND; Seidmon EJ; Maurer AH
J Nucl Med; 1997 Apr; 38(4):525-8. PubMed ID: 9098195
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of technetium-99m methylene diphosphonate myocardial uptake: association with carcinoma of the prostate.
al-Nahhas AM; Jinnouchi S; Anagnostopoulos C; Hirsch W; Heary T; McCready VR
Eur J Nucl Med; 1995 Feb; 22(2):148-53. PubMed ID: 7758502
[TBL] [Abstract][Full Text] [Related]
29. Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication.
Mele M; Conte E; Fratello A; Pasculli D; Pieralice M; D'Addabbo A
J Nucl Med; 1983 Apr; 24(4):334-8. PubMed ID: 6834136
[TBL] [Abstract][Full Text] [Related]
30. Lymph node visualisation: an unusual artefact in the 99mTc-pyrophosphate bone scan.
Chatterton BE; Vannitamby M; Cook DJ
Eur J Nucl Med; 1980 Apr; 5(2):187-8. PubMed ID: 6247156
[TBL] [Abstract][Full Text] [Related]
31. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
[TBL] [Abstract][Full Text] [Related]
32. Gallium-67 and technetium-99m-methylene diphosphonate skeletal scintigraphy in determining prognosis for children with stage IV neuroblastoma.
Macdonald WB; Stevens MM; Dalla Pozza L; Bergin M; Menser MA; Howman-Giles R; Uren RF
J Nucl Med; 1993 Jul; 34(7):1082-6. PubMed ID: 8315482
[TBL] [Abstract][Full Text] [Related]
33. Electrophoretic analysis of different technetium-99m (SnCl2) methylene diphosphonate complexes.
Najafi A; Hutchison N
J Nucl Med; 1985 May; 26(5):524-30. PubMed ID: 3157787
[TBL] [Abstract][Full Text] [Related]
34. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.
Taillefer R; Robidoux A; Lambert R; Turpin S; Laperrière J
J Nucl Med; 1995 Oct; 36(10):1758-65. PubMed ID: 7562039
[TBL] [Abstract][Full Text] [Related]
35. Labeling efficiency and stomach concentration in methylene diphosphonate bone imaging.
Dhawan V; Yeh SD
J Nucl Med; 1979 Jul; 20(7):791-3. PubMed ID: 541718
[TBL] [Abstract][Full Text] [Related]
36. Serendipitous lymph node visualization during bone imaging.
Vieras F
Clin Nucl Med; 1986 Jun; 11(6):434. PubMed ID: 3720158
[No Abstract] [Full Text] [Related]
37. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
Subramanian G; McAfee JG; Blair RJ; Kallfelz FA; Thomas FD
J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385
[TBL] [Abstract][Full Text] [Related]
38. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
39. Fortuitous lymph node visualization after interstitial injection of Tc-99m-MDP.
Penney HF; Styles CB
Clin Nucl Med; 1982 Feb; 7(2):84-5. PubMed ID: 6460582
[No Abstract] [Full Text] [Related]
40. Extraosseous Tc-99m MDP uptake: a pathophysiologic approach.
Peller PJ; Ho VB; Kransdorf MJ
Radiographics; 1993 Jul; 13(4):715-34. PubMed ID: 8356264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
